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The Truth About Torts: Defensive Medicine and the Unsupported Case for Medical Malpractice 'Reform'
• Physician surveys -the most heavily cited evidence of "defensive medicine" -are so misleading, suggestive, and poorly designed that the Government Accountability Office (GAO) has condemned them as valueless. Although a favorite of civil justice system opponents, physician surveys on the topic suffer from dismally low response rates, exploit physicians' availability bias, offer prompting questions, employ extremely broad questions, and fail to follow up in relevant and meaningful ways.
In the end, these surveys only measure the prevalence of physicians' concerns about litigation and the influence of the availability bias.
• Perhaps because of all the attention given to tort reform proposals, physicians greatly overestimate the prevalence of lawsuits and verdicts against them, leading them to support tort reforms that will have little impact on their medical malpractice premiums. In fact, the vast majority of victims of malpractice do not sue, and of those who do, most have a valid claim. Most doctors will see, on average, only one malpractice claim in their careers, and just 7 percent may see a claim in any given year. Recent research shows that medical malpractice claims have been in steep decline for more than ten years. Unfortunately, tort reform also has almost no impact on physicians' fears of litigation, so even severe restrictions will do nothing to change their views of the civil justice system.
The evidence reveals that "defensive medicine" is largely a myth, proffered by interests intent on limiting citizen access to the courts for deserving cases, leaving severely injured patients with no other recourse for obtaining the corrective justice they deserve. These changes would limit the deterrent effect of civil litigation and diminish the regulatory backstop that the civil justice system provides to the professional licensing system, leading to more medical errors.
Restricting lawsuits might save doctors a negligible amount on malpractice premiums but the vast majority of any savings will most certainly line the pockets of the insurance companies demanding these restrictions. 4 On the other hand, buying into this myth has very real and dangerous consequences. Allowing civil justice opponents to pretend that constraining the civil justice system equates to meaningful health care reform distracts us from doing the things that must be done to fix the system, including avoiding the 98,000 deaths caused by preventable medical errors every year 5 and reducing the unacceptable number of uninsured Americans. 
Why the Civil Justice System Matters, and What it Really Looks Like
The civil justice system performs two important roles in society. First, it allows wrongfully injured people to obtain just compensation for their injuries. This compensatory role also performs a corrective justice function, meting out the justice that society has determined the bad actor deserves. Second, civil lawsuits act to deter unreasonably risky or harmful conduct with the goal of preventing similar conduct from occurring in the future. As the experience of the anesthesiologists demonstrates, the deterrent function creates an incentive for improvements in the medical standard of care.
Case study: The Anesthesiologists
In response to the medical malpractice "crisis" of the 1980s, the American Society of Anesthesiologists undertook a massive project to identify every malpractice claim that had ever been made against an anesthesiologist. The anesthesiologists found that over a third of all claims against them sprang from very damaging, but very preventable, adverse events. Rather than fighting to limit patients' rights, however, the professional organization instead pushed for better equipment, improved guidelines, and physician education. Today, anesthesiology has achieved the lowest error rate of any medical specialty -just four deaths per million exposures -and practitioners' premiums are around the same levels they were in the 1980s. The anesthesiologists' experience shows that reducing needless harm to patients serves everyone's interests by reducing the number of negligent injuries and deaths while decreasing physicians' malpractice insurance premiums dramatically.
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In the health care sector, the deterrent function also reinforces the professional licensing system. Malpractice suits ensure, and improve, patient safety beyond what the professional licensing system is able to provide, which is important because the regulatory framework, including state medical licensing boards, is slow to discipline physicians. 7 The civil justice system fills the gap left by licensing boards, adding an additional incentive to improve patient safety and providing for more protective and progressive compensation and justice. In addition, the civil justice system, including medical malpractice litigation, reveals underlying problems with private organizations, signaling regulators and legislators of the need for reform. 8 Notwithstanding the important role of civil litigation, medical malpractice litigation is infrequent. Every year, fewer than 85,000 total medical malpractice lawsuits are filed, 9 less than the number of deaths due to preventable medical errors alone. In 2010, the National Center for State Courts reported that, at the same time that civil caseloads have been increasing by up to 5 percent every year, malpractice claims are in steep decline, down 15 percent from 1999 to 2008. 10 In fact, "just as torts typically represent a single-digit proportion of civil caseloads, medical malpractice cases comprise a similar proportion of torts. Despite their continued notoriety, rarely does a medical malpractice caseload exceed a few hundred cases in any one state in one year."
11 Lawsuits are simply rare events in a physician's career, notwithstanding the horror stories they may hear from their colleagues. 12 It is actually a small group of negligent doctors that is responsible for most of the malpractice claims made every year. Since its inception in 1990, the National Provider Data Bank has tracked all malpractice payments from insurers, physicians, and hospitals to injured patients. Between 1990 and 2005, 82 percent of physicians made no malpractice payments while 5.9 percent were responsible for 57.8 percent of all payments. 13 Moreover, according to the Henry J. Kaiser Family Foundation, the average number of malpractice claims per doctor dropped from 25 claims per 1,000 active physicians in 1991 to 18.8 in 2003. 14 As the authors of the Harvard Medical Malpractice Study observed, "medical malpractice litigation infrequently compensates patients injured by medical negligence and rarely identifies, and holds providers accountable for, substandard care." 15 The best empirical research shows that most victims of medical malpractice never even make a claim, let alone sue. Indeed, studies over the last three decades suggest that less than 20 percent of victims of medical negligence file a lawsuit. 16 Moreover, Professor Tom Baker, of the University of Pennsylvania Law School, says that "because hospital record reviews miss so much medical malpractice," the real rate is likely even smaller than such studies show. 17 Looking at these types of studies deeper shows that patients who suffer a serious injury from medical malpractice sue less than 5 percent of the time. In a hospital observation study in Chicago, the researchers found that 185 of 1,047 patients suffered a preventable serious injury. Of those 185, just 13 asked the hospital or doctor for compensation and just 6, or less than 4 percent, filed a lawsuit. Other evidence shows that a majority of those victims who do file a claim have suffered an injury for which they are eligible for compensation. In fact, just 3 percent of claims have no verifiable injuries. 19 Finally, the vast majority of malpractice claims that lack evidence of negligence are not compensated, and many of those claimants may have simply used litigation as their sole source of information about their injury. What is most likely in those cases, which research suggests may account for a third of claims, 20 is that a patient who suffered an adverse event sued, only to find out during discovery or negotiations that, although there was a bad outcome, there was no error. 21 These findings do not support "the notion of opportunistic trial lawyers pursuing questionable lawsuits" but rather "underscore how difficult it may be for plaintiffs and their attorneys to discern what has happened before the initiation of a claim and the acquisition of knowledge that comes from" the process of litigation.
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This data shows that when a healthy civil justice system and regulatory framework are working in tandem, robust "regulatory pluralism" flourishes, patient safety becomes paramount, and justice is served. 23 Given the importance of the civil justice system, policymakers should be skeptical of proposals to restrict citizen access to the courts and other efforts to hobble this institution. Opponents of the civil justice system should face a high bar to justify their effort to eliminate civil justice opportunities for medical malpractice victims. As we will show, they have not met that burden.
Physician Behavior and Motivation
Opponents of the civil justice system place the blame for variations in medical decisionmaking squarely on the civil justice system. However, such variations are actually the result of differences in medical judgment and other motivations such as the influence of advertising and the Internet on patient demands, financial gain, and the simple availability of technology, among others. Efforts to estimate the extent of "defensive medicine" have been unable to untangle these various motivations. Moreover, physician decisionmaking is subject to insurance company and government oversight, which requires standardized approaches and certification as to the medical necessity of physicians' decisions.
What is Medical Malpractice?
Medical malpractice is a form of tort liability under which doctors are liable for injuries to their patients caused by the doctor's failure to meet the high standard of care expected of medical professionals. The standard of care applicable to medical malpractice is that of a reasonable physician under the same or similar circumstances. However, regarding some medical presentations, there may be no "scientifically proven, universally agreed-upon treatment." Faced with the exact same medical circumstances in the same patient, two physicians may respond in significantly different ways, neither of which is negligent. While opponents of civil justice may draw on these variations to bolster their "defensive medicine" claim, they often simply reflect acceptable differences in medical judgment.
Complicated Motivations to Practice 'Extra Medicine'
In order to understand physician behavior, we must first understand that the incidence of "defensive medicine" as a behavior is very hard to quantify, because the concept itself lacks a clear and consistent definition. Despite serious flaws, the most widely used definition comes from a 1994 U.S. Congress Office of Technology Assessment (OTA) report on the topic. According to the OTA, positive "defensive medicine" occurs when physicians "order tests, procedures, or visits, or avoid certain high-risk patients or procedures, primarily (but not solely) because of concern about malpractice liability."
24 When applied to the real world, however, the OTA definition of "defensive medicine" is over-inclusive, because it cannot account for the various motivations that may lie behind medical decisions. Civil justice opponents, meanwhile, have exploited this imprecise definition to exaggerate the extent to which the practce occurs.
Although it used an over-broad definition of "defensive medicine," the OTA's 1994 report is nevertheless instructive when it comes to explaining physician behavior. In that report, the OTA conducted clinical scenario surveys in which physicians were asked how they would respond to hypothetical patient scenarios. Importantly, physicians were told the survey The Truth About Torts: Defensive Medicine and the Unsupported Case for Medical Malpractice 'Reform' was designed to study decisionmaking and made no reference to medical malpractice, thus eliminating any bias on the part of the respondents.
In their responses, physicians were asked to indicate all their reasons, including the most important, for their clinical decision. Surprisingly, just 8 percent of responses indicated that they would order a procedure for defensive reasons. Even more interesting, physicians said that litigation fear was the single most important reason for their decision in just 0.5 percent of the responses. Indeed, those numbers are likely to be even less than reported because the study was "specifically designed to increase the likelihood of defensive response by physicians." 25 Finally, some of the surveys were open-ended, in which doctors were given a blank space to list the reasons for their clinical decision. In those surveys, even fewer physicians listed litigation fears as a reason behind their medical decisionmaking than did when that explanation was offered as one of several boxes the physicians could check. 26 In the end, the OTA concluded that their clinical scenario surveys support the "large body of evidence that there is a great deal of variation in how physicians practice medicine."
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So what drives physician decisionmaking? Although it is very challenging to unravel, motivations such as financial gain, the desire to maintain a good doctor-patient relationship, acceding to patient demands due to the influence of advertising by the medical industry, "the simple availability of sophisticated technology, . . . time constraints that limit the physician's willingness to contemplate data before ordering a test, the fear of missing a crucial diagnosis, and simple zeal for the attainment of diagnostic certainty" are some of the largest drivers. 28 The CBO notes, "some so-called defensive medicine may be motivated less by liability concerns than by the income it generates for physicians or by the positive (albeit small) benefits to patients." 29 The follow-up study by Kessler and McClellan, discussed below, supports this conclusion, that extra medicine as we know it may just as likely be "an artifact of the traditional fee-for-service payment system," 30 driven more by financial incentives than litigation. The GAO also recognized the potential for profit motives to alter medical decisionmaking in its critique of physician surveys regarding "defensive medicine." In that report, GAO conducted interviews with AMA officials, hospital administrators, and physicians around the country in which one administrator in Montana admitted that "revenue-enhancing motives can encourage the utilization of certain types of diagnostic tests." 31 In a now widely cited article for The New Yorker, Atul Gawande, a surgeon and professor at Harvard Medical School, provided insight into the profit motive that is enmeshed in parts of medical practice in this country. 32 Gawande visited McAllen, Texas, a mid-size city that has the honor of being one of the most-expensive health care markets in the country. Years before his visit, Texas passed aggressive tort reforms that were sold on the premise that they would reduce the cost of health care for everyone in the state. Instead, what Gawande found in McAllen were high medical costs, low quality care, and a culture of overutilization driven by profit. In El Paso, a similarly situated city with nearly equivalent socio-economic metrics, Medicare spending was half that of McAllen's. Since both cities are in Texas, litigation could not be driving these differences; after all, malpractice litigation had declined severely in the state by the time of Gawande's article. 33 In short, what Gawande found was that a significant expansion of physician-owned imaging and surgery centers and hospitals in McAllen means physicians there are more invested in the marginal profits from increased medical care than their counterparts in El Paso without being sensitive to the marginal benefits of that care to their patients. As a result, patients in McAllen receive significantly more operations, hospital admissions, diagnostic imaging, and specialist referrals. This is consistent with other highcost regions where patients get substantially "more high-cost care across the board, but less low-cost preventive services and primary care, and equal or worse survival, functional ability, and satisfaction with care." 34 Although the profit motive and patient demands certainly influence physician behavior, many motivators -including the culture of medicine itself, an overly complex insurance structure, and a distorted financing system -combine to drive physician behavior toward "overuse" of medical testing and procedures. A physician who has had to discuss their mistakes in a morbidity and mortality conference -where physicians discuss their failed medical cases -will likely avoid making the same mistake ever again, but may also begin overusing certain medical procedures and tests to avoid it. This is different than defending herself against a potential lawsuit; she is rightly trying to avoid a mistake because doctors are expected to do no harm. Physicians also now operate in a culture of testing, taught to see testing as a standard way of achieving diagnostic certainty, sometimes using overtesting as a crutch, or even influenced by patients' perceptions that more testing means better care. 35 In short, medical decisionmaking is subject to a complex web of motivations, yet advocates for civil justice restrictions focus on the theory of "defensive medicine" while ignoring other incentives such as the fear of making a mistake, technology availability, and a fee-for-service system that rewards the wrong behavior.
Surgery at the End-of-Life
End-of-life decisions by patients, their families, and their physicians are an additional example of just how hard it is to untangle the varied motivations underlying medical decisionmaking. A recent Lancet study found that one in three patients had surgery in the last year of their life, one in five in the last month, and one in ten in the last week of life. 36 While the study has its limitations -many of these surgeries may have had very real benefits -any doctor will acknowledge that some surgeries are undertaken that may remedy one ailment or another but that will not extend the life of a patient. In fact, end-of-life surgeries can expose a patient to additional pain and risk. Yet, because surgery can be tempting as a silver bullet, it can stand in as a substitute for frank discussion about a patient's end-of-life goals. Civil justice opponents might call end-of-life surgeries "defensive medicine." What they represent, instead, is the diverse set of motivations influencing medical practice today.
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Limiting Extra Medicine with Managed Care
In light of this evidence, extra medicine "may represent physician conduct that would have occurred for other reasons even in the absence of sincere legal fears." 37 Whatever the motivation, physicians are highly trained experts who are paid to exercise their judgment efficiently and cost-effectively. If they fail to do so, Medicare or the insurance company, both very sophisticated actors, will take notice.
The variation in physician decisionmaking is significantly limited by the growth of managed care and the restrictions imposed by insurance companies, which require physicians to offer medical reasons for their decisionmaking. Managed care plans "limit the use of services that have marginal or no benefit to patients (some of which might otherwise be provided as 'defensive medicine')." 38 The financial interest of insurance companies in minimizing costs provides an institutional counter-weight to extra medicine. In fact, the GAO's analysis of current research found that "managed care provides a financial incentive not to offer treatments that are unlikely to have a medical benefit."
39 Those claiming that "defensive medicine" is caused by litigation fears ignore the important impact of managed care in limiting extra medicine.
Medicare should provide a second countervailing force against unnecessary testing and procedures intended to temper the incentives for overutilization that its fee-for-service structure creates. Providing care that is not aimed at benefitting the patient, and then billing Medicare, is fraud. Medicare requires physicians to certify that services they bill for were medically indicated and necessary. If the services were not, and the doctor still bills Medicare, they can be prosecuted for fraud. As one former physician puts it, "[i]f tests are being performed that assist the doctor in determining a diagnosis or treatment, then they are not unnecessary . . . If doctors perform unnecessary tests, they are likely doing it for the money . . . This practice is nothing new. It used to be called fraud; now the [American Medical Association] calls it defensive medicine." 40 As the experience in McAllen, Texas showed, however, this oversight function may not always be as effective as it should be.
The Absence of a Case for Civil Justice Restrictions
The evidence supporting the incidence of "defensive medicine" is remarkably weak considering the widespread acceptance of the myth. Reliable estimates put the total cost of defending malpractice suits and paying injured victims at less than 0.3 percent of all health care spending, 41 yet opponents of the civil justice system make the unsupported claim that "defensive medicine" -in theory practiced in response to those same small malpractice costs -is responsible for 30 times that amount. 42 As will be discussed, the real drivers of health care spending and malpractice premiums -an aging population that requires increasingly more complicated care and insurance market cycles that drive industry business decisionsare unrelated to litigation or "defensive medicine." Further, this section surveys the empirical evidence showing that "defensive medicine" has little impact on health care costs and that civil justice restrictions save very little money while hurting many people. Finally, we review the evidence marshaled by opponents of the civil justice system and show how little it actually proves. Those opponents rely primarily on a study that the CBO and others have disputed and that the authors themselves substantially revised, and on surveys of physicians that are hopelessly unreliable.
Medical Malpractice Litigation is Not Responsible for Rising Health Care Costs or Physician Premiums
Opponents of the civil justice system contend that "defensive medicine" is driven by physicians' perceptions of their litigation risk, for which their premiums serve as a proxy. 43 When premiums rise, physicians, medical societies, and politicians complain about a "tort crisis," and seek draconian civil justice restrictions in response. The available evidence suggests, however, that their ire is misplaced and the requested prescription will not alleviate their pain. The sometimes-high costs of medical malpractice insurance are driven almost entirely by the economic behavior of insurance companies themselves, not medical malpractice litigation, which has been in decline for years. Meanwhile, exploding health care costs are barely affected by the small contribution of the medical liability system, which is, again, not growing.
Rising Health Care Costs Have Little to Do with Malpractice Litigation
The rhetoric about an alleged malpractice litigation "crisis," appeals to very real concerns about the escalating cost of health care in this country, and the diminishing returns from those expenditures. The United States today spends more on health care than any other country, approximately 17.6 percent of GDP or $8,086 per capita. What's more, this huge expenditure has grown at an average of 5 percent per year for the last four decades. 45 However, only a very small portion of health care spending is attributable to medical malpractice litigation or "defensive medicine." A recent study suggests that the entire The Truth About Torts: Defensive Medicine and the Unsupported Case for Medical Malpractice 'Reform' medical liability system, including costs attributable to "defensive medicine," costs the nation $55.4 billion, or about 2.4 percent of all health care spending. 46 While acknowledging that the data on "defensive medicine" is weak, the authors attributed 80 percent of the total to "defensive medicine." Since, as shown below, the evidence used by opponents of civil justice greatly overestimates the frequency and, therefore, costs of "defensive medicine," 47 that percentage is very likely much smaller.
What is really driving the rapid growth of health care costs are a host of factors that include technology gains, chronic disease, an aging population, and runaway administrative costs. The development of more expensive state-of-the-art medical technology is by far the largest contributor to increases in health care spending, contributing between 38 and 65 percent of all growth in health care spending. 48 This is due, in part, to the industry's desire to recover the costs of technology development and the influence of advertising on consumer demand. 49 The development of new prescription drugs has had a similar influence on costs.
Additional growth in spending is also the result of an aging population and the greater prevalence of chronic disease, including heart disease, diabetes, cancer, and respiratory diseases. As life spans have increased and lifestyles have become unhealthier in the United States, chronic disease has had a greater influence on health care costs. The Centers for Disease Control and Prevention estimate that, between 1987 and 2001, "increases in obesity prevalence alone accounted for 12 percent of the growth in health care spending." 50 Today, up to 75 percent of all health care dollars are spent on people with chronic conditions. 51 Moreover, as baby boomers age, and become eligible for Medicare, their health care costs are increasing, though this factor has a smaller influence on rising health care costs than either technology or chronic disease among the general population. 52 Finally, the combined private-public insurance model currently employed in the United States leads to wasteful and inefficient administrative costs due to high overhead and huge insurance industry profits. 53 Some estimates put the cost of administration at 7 percent of all health care costs. Other inefficiencies, such as the prevalence of fee-for-service payment models that create the incentive for physicians to provide more services rather than practice efficiently, also drive up costs. 54 On the other hand, evidence that malpractice litigation "perceptibly raises the growth of health care spending is almost nonexistent." 55 Even as the United States far outpaces all other countries in health care spending, we still fail to provide insurance to more than 50 million citizens. 56 Meanwhile, adverse events in hospitals, both negligent and not, lead to as many as 187,000 deaths and up to 6.1 million injuries every year, according to a 2011 study. 57 Yet, neither the discussion about health care spending nor the red herring arguments about tort reform and "defensive medicine" consider the value of avoiding such adverse events. One recent study did just that, estimating the annual social cost of adverse medical events at between $393 and $958 billion, or the equivalent of 18 to 45 percent of all health care spending in the United States. 58 Even the lower estimate far exceeds the annual measurable cost of medical errors, or preventable adverse events, of $17 to $29 billion. 59 Since the best estimates of the costs of malpractice litigation and so-called "defensive medicine" are a fraction of these figures, it is readily apparent that tort reformers are not really concerned with patient safety or health care costs. They are simply opponents of the American civil justice system and interested only in ensuring corporate and individual immunity from lawsuits.
The Malpractice Insurance Market is What Really Drives Physician Premiums
What really influences the medical malpractice insurance market is not lawsuits but the nature of the insurance industry itself. In fact, malpractice claim payouts are not solely, or even primarily, responsible for how insurance companies base malpractice premium rates. 60 When insurance companies take in physician premiums, they know that they will not pay money out for claims on those premiums for several years. Instead, they invest that money, hope to get high returns before they have to pay claims, and, meanwhile, try to predict their future losses. Those predictions, in turn, influence how much money insurers set aside to pay future claims, what the industry calls "reserves."
The "loss" reported by an insurance company in a given year is just an estimate because of the time it takes to resolve a claim. Thus, an insurance company may report a loss that year that it later adjusts significantly once it knows exactly how much it had to pay out. If a company finds that its losses will not be as high as predicted, and has over-reserved in anticipation thereof, it will incur a profit.
The insurance underwriting cycle is characterized by a fluctuation between "soft" and "hard" markets. During a soft market, insurance is easier to get because insurance companies are competing for market share and premium rates decline. Insurers are also less restrained, overly optimistic about their future losses, and tend to hold lower reserves. As the market becomes saturated, rates decline too much, insurance profits fall, and a hard market ensues. Premium rates skyrocket as insurers begin over-reserving, become more conservative in predicting their losses, and more selective in whom they choose to insure. The transition from a soft to a hard market is hard to predict, but the shift is obvious. More importantly, analysts suggest that the cycle is unavoidable. 61 Malpractice "crises" arise after a soft market, when insurance companies are overly optimistic about their predicted losses, leading them to sell underpriced policies and to under-reserve. When, a few years later, actual losses exceed their predictions, insurers have to recover, leading them to charge higher prices for premiums in order to expand their reserves. This is precisely what happened in the crises of the late 1980s and early 2000s. When the most recent "crisis" occurred, in the early 2000s, the end of the particularly competitive soft market of the 1990s happened to coincide with September 11th, the bursting of the Internet bubble, and subsequent declines in the stock market. During that soft market, new entrants to the malpractice insurance market initiated a price war as they tried to undercut each other and win a market share of what appeared to be a lucrative industry but was really an industry fueled by inflated profits secured through accounting gimmicks. 63 The industry then exploited news of their declining investment returns from the contracting stock market and predicted steep incurred losses for the early 2000s. Premiums went up, physicians got angry, and calls for tort reform were renewed. Importantly, those incurred losses were later significantly revised downward -by an average of 12.6 percentsuggesting that insurance companies had sufficient funds and were simply over-reserving even during the highly competitive soft market of 1990s. In short, the most recent medical malpractice insurance "crisis" was entirely fabricated by the insurance industry itself, exaggerating their losses while enjoying some of the highest profits among all American businesses. Meanwhile, the civil justice system, and restrictions put in place in response to the "crisis," have had little to no effect on insurance premiums. After all, there was no sudden explosion of jury verdicts or malpractice settlements to accompany the crisis.
The California Tort Reform Experience: Saved by Proposition
In 1975, California passed a major tort reform package in response to one of the first malpractice insurance "crises." The Medical Injury Compensation Reform Act (MICRA) serves as the model for the federal legislation proffered during each crisis and is the source of civil justice opponents' preferred, and unadjusted-for-inflation, cap of $250,000 on non-economic damages. Yet, while opponents of the civil justice system contend that MICRA is proof that civil justice restrictions work the way they say they do, malpractice insurance premiums in California continued to increase -by 450 percent -for 13 years after MICRA was passed. Notably, it was only after Californians passed the nation's most stringent insurance reforms, by proposition, that premium rates finally stabilized. Recent work by economists at Dartmouth confirms that malpractice payments do not drive increases in provider premiums, that changes in premium costs do not affect the overall size of the physician workforce, and that there is no evidence that increases in premium costs change the use of treatments. 64 Instead, the authors posit that what drives premium changes are industry competition and the nature of the insurance underwriting cycle. In other words, the threat of litigation is not affecting medical malpractice premiums.
Empirical Evidence Shows 'Defensive Medicine' Has Little Impact on Either Health Care Costs or Malpractice Premiums and is Not Influenced by Tort Reform
A review of the empirical evidence indicates that litigation has a negligible impact on health care costs. In the study mentioned earlier, the OTA also found very small costs from defensive radiology in children and caesarean sections in difficult pregnancies. However, the OTA concluded, "it is impossible in the final analysis to draw any conclusions about the overall extent or cost of defensive medicine."
65 Today 37 states have passed some limit or cap on damages, 66 including Texas and California, states with some of the highest health care costs and physician premiums, and still opponents of the civil justice system claim that both litigation and "defensive medicine" are rampant. There is simply no reliable evidence that malpractice litigation creates "defensive medicine" or raises the level of health care spending. 67 In a comprehensive review of New York doctors, the Harvard Medical Practice Study observed that, despite being told by physicians that lawsuits affected their practice, there is not a strong relationship between the threats of malpractice litigation and medical costs. 68 In 1999, researchers at the Urban Institute found a small correlation between malpractice premiums and cesarean rates. However, they also found that if civil justice restrictions were capable of reducing premiums by half -an unlikely proposition, though not unheard of from civil justice opponents -it would lead to a cost savings of just 0.27 percent, 69 demonstrating how little impact so-called "defensive medicine" has on the cost of medical practice.
A more recent review of more than 400 million health care claims found further evidence that "defensive medicine" contributes an almost imperceptible amount to health care costs and is susceptible of very little influence from trends in physicians' malpractice premium costs. 70 The authors found that a 10-percent reduction in malpractice premiums was associated with a savings of just 0.132 percent. Even a 30-percent reduction in malpractice premiums would lead to just a 0.4-percent decrease in health care costs. 71 In other words, if the country cut back significantly on the rights of medical malpractice victims to sue and recover for their injuries, and this produced a 30-percent reduction in medical malpractice premiums (which is unlikely since premiums are a function of insurers' business practices), the nation would save only a tiny fraction of health care costs.
The Kessler & McClellan Study Does Not Support Civil Justice Opponents' Claims
In their battle to restrict plaintiffs' access to the courts, civil justice opponents have relied heavily on a study by Daniel P. Kessler and Mark McClellan estimating that civil justice restrictions could save "well over $50 billion per year without serious adverse consequences for health outcomes." 72 In fact, the study's economic analysis is only applicable to a very narrow set of heart ailments and outside researchers have been unable to verify the estimate. Even its authors have subsequently revised their findings to a significant extent, an inconvenient fact that civil justice opponents ignore.
The Original Study
In 1996, Kessler and McClellan released a paper that looked at three years of Medicare data for elderly heart patients who received a number of specific treatments. 73 The authors concluded that states that enacted certain civil justice system restrictions saw declines in the use of "defensive medicine" of 5 to 9 percent, but that those savings diminished within a few years. 74 The authors then extrapolated those findings to the entire health care system and speculated that such savings would be uniformly realized regardless of differences in ailments, physician specialties, or insurance structures. This wholly unjustified extrapolation has become the source of one of the most prominent estimates used by civil justice opponents in their effort to take away citizens' rights: that "if " their findings were generalizable, civil justice restrictions could save the health care system "well over $50 billion per year." 75 The extrapolation is highly problematic. Unlike the remainder of the paper, it is mere conjecture, a profoundly big "if " embedded in a conclusion with no empirical basis for support of any kind. The actual analysis, while sound so far as it goes, is too narrow to be extended beyond its limits. The authors focused only on elderly Medicare patients, with heart conditions, in hospital settings, in one state, Florida. 76 No effort was made to control for patient age, the widespread shift toward managed care (and away from fee-for-service arrangements), other medical conditions, different health care settings, or differences among states. Moreover, the authors admit that the procedures they examined were particularly susceptible to overuse. Even so, the authors suggested that generalizing their findings to the entire national health care system was both logical and reasonable. 77 Finally, another failing of Kessler and McClellan's paper is that it applied then-current and evolving standards of treatment to care that was provided years earlier. own research suggests that heart conditions in elderly patients are "unusually prone to wasteful defensive medicine" and that many of the most expensive treatments for heart conditions have very small marginal benefits. 78 However, this research on the marginal benefits of expensive heart treatments was not published until well after the years that Kessler and McClellan studied for their 1996 paper. 79 Thus, the physicians who ordered the expensive treatments upon which the 1996 paper was modeled were not aware of the fact that they were ordering additional, unproductive medicine. They were treating heart conditions according to the medical knowledge and the standard of care at the time. What McClellan's subsequent research demonstrates is that medical research, not tort reform, can limit the overuse of expensive procedures by improving medical knowledge and thus aiding the evolution of the standard of care.
The Updated Study
In 2002, Kessler and McClellan revisited their work, evaluating more data and controlling for managed care. This led to a downward adjustment of their original estimate and a conclusion that direct tort reforms reduce health care costs for elderly heart patients in Medicare by only 4 percent. 80 The authors attributed this reduction in heart disease expenditures to the "spillover effect" of managed care on traditional Medicare. In other words, managed care's focus on cutting costs while providing more benefits is effective at reducing excessive medical procedures and tests, without inducing declines in patient safety or enacting draconian civil justice restrictions. Despite this downward adjustment, the 1996 paper carries much more weight among civil justice opponents, even today.
The Extrapolation Cannot Be Verified
The 1996 study suffers from another critical shortcoming: neither government agencies nor academic researchers have been able to extrapolate Kessler and McClellan's findings to other ailments or to more recent years. In 1999, the GAO issued a report on malpractice laws in the District of Columbia, Maryland, and Virginia in which it reviewed the Kessler and McClellan paper, among other studies, and concluded that, "[g]iven the limited evidence, cost savings estimates [from civil justice restrictions] cannot be developed." 81 Indeed, the GAO pointed out " [b] ecause [the Kessler and McClellan] study was focused on only one condition and on a hospital setting, it cannot be extrapolated to the larger practice of medicine." 82 In 2004, the CBO tried to extend Kessler and McClellan's study. 83 Applying the same methods Kessler and McClellan used in their study to a broader set of ailments, the CBO "found no evidence that restrictions on tort liability reduce medical spending." 84 Additionally, using a different set of data, the CBO "found no statistically significant difference in per capita health care spending between states with and without limits on malpractice torts." Adopting the same distinctions between "direct" and "indirect" reforms, but looking at other ailments in addition to heart problems and using patient data from both Medicare and private insurance, the authors failed to find significant effects of tort reform on cost or patient outcomes. 86 The authors concluded that "tort reforms do not significantly alter medical decisions, nor do they have a systematic effect on patient outcomes." 87 Similarly, Katherine Baicker and Amitabh Chandra, economists at Dartmouth University, found little or no relationship between medical practice and malpractice litigation risk. In fact, they concluded that " [t] he fact that we see very little evidence of . . . dramatic increases in the use of "defensive medicine" in response to state malpractice premiums places the more dire predictions of the malpractice alarmists in doubt."
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CBO Letter Contradicts Prior CBO Reports
In 2009, civil justice opponents received an unexpected gift from the CBO, which, after completing an analysis at the request of Sen. Orrin Hatch, sent a surprisingly brief letter claiming that significant savings could be realized from civil justice restrictions. 89 In his letter, the Director of the CBO, Douglas Elmendorf, suggests that a package of aggressive civil justice restrictions would reduce national health care spending by about $11 billion or 0.5 percent. 90 Of that total, the CBO states that 40 percent is from lower liability premiums and 60 percent is from slightly reduced utilization of health care services attributable to what might be characterized as a reduced level of "defensive medicine." The CBO's letter relies almost exclusively on Medicare research, including resurrecting the study by Kessler and McClellan that the CBO itself dismissed in 2004. 91 The letter fails to address the limits of comparing Medicare, with its emphasis on fee-for-service, to private health care providers, which have moved more heavily toward managed care. Because the data is more readily available, researchers tend to use Medicare data for economic research. However, as the limitations of Kessler and McClellan's work show, Medicare has a different structure, different incentives, and different spending patterns than private health care. This makes generalizations based on Medicare data inapt, at best. Indeed, the CBO's letter, while singularly focusing on Medicare research, failed to find evidence of "defensive medicine" in private managed care. If "defensive medicine," as defined by the CBO, existed to the extent that the CBO suggests, this disparity would not be expected. After all, the civil justice system applies to everyone, regardless of age, so the fact that a litigant might come out of Medicare or not is inapposite. Doctors should theoretically be practicing "defensive medicine" universally, unless there are other explanations, such as Medicare's emphasis on a fee-for-service payment structure, which the CBO essentially admits in the letter.
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The CBO's package of civil justice restrictions it would need to accomplish the savings it predicts is also very aggressive, and unrealistic. The proposals include a $250,000 cap on 93 a one-year statute of limitations for adults; and a repeal of the centuriesold tort doctrine of joint-and-several liability. 94 These are not middle of the road suggestions, they are cruel limits on the rights of plaintiffs to seek justice which have been rejected, or found unconstitutional, by many of the states that have considered tort "reform."
95 Surprisingly, for the usually meticulous agency, several of the studies cited by the CBO in its letter directly contradict its conclusions, suggesting that the CBO was over-reaching in finding support for its thesis. Some of the cited studies suggest that civil justice restrictions are, in fact, unlikely to have major impacts on health care spending or outcomes, may not be cost-effective, might increase procedure use in some cases, and could increase mortality rates. 96 One paper cited by the CBO states that civil justice restrictions are "likely to be cost-ineffective" and "more likely to harm than improve social welfare." 97 Another states unequivocally that the authors' estimates "do not imply that any change in spending was necessarily 'defensive medicine'" and that "additional procedures may be protective of patient health or valued regardless of therapeutic properties." 98 The CBO even cites Frank Sloan and John Shadle's 2009 study, which weakened Kessler and McClellan's findings, but ignores the authors' conclusion that "it seems inappropriate to conclude that tort reforms implemented to date succeed in reducing non-beneficial care as their proponents would have it." 99 Finally, the CBO also ignores the potential for civil justice restrictions to lead to additional deaths and injuries from medical malpractice, which one paper cited by the CBO suggests could be as high as 5,000. 100 What is perhaps most striking about the CBO letter, though, is the rare departure from years of careful analysis. The CBO's past work found small savings from civil justice restrictions and declared the evidence on "defensive medicine" to be "weak or inconclusive" and "at best ambiguous." 101 Another CBO report, in 2004, described the limits of Kessler and McClellan's 1996 Medicare research by concluding, "those studies were conducted on a restricted sample of patients, whose treatment and behavior cannot be generalized to the population as a whole." 102 In fact, just ten months before its letter to Senator Hatch, the CBO concluded that there is insufficient evidence that civil justice restrictions would reduce health care costs. 103 The past work speaks for itself. Little changed in the research on defensive medicine in the years between CBO's prior analyses and its letter to Senator Hatch.
Physician Surveys are the Most Unreliable -but Most Cited -'Evidence' of 'Defensive Medicine'
Opponents of plaintiffs' access to courts often cite physician surveys to support their desired restrictions on civil justice, but such surveys are highly susceptible to manipulation aimed at generating desired results. These casual surveys are so flawed that they provide no reliable evidence regarding "defensive medicine," and have been condemned as valueless by the GAO. 104 They are often poorly designed, casting a wide net not intended to capture a representative sample; ask leading questions; and fail to ask relevant follow-up questions.
The Truth About Torts: Defensive Medicine and the Unsupported Case for Medical Malpractice 'Reform' They are also susceptible to bias: Those that respond do so because they are vested in the outcome, while others respond with the answer they believe is being sought. Some surveys do not even feign objectivity, asking physicians whether they agree with statements about the widespread practice of "defensive medicine" or the effects of civil justice restrictions on the pracice of "defensive medicine." 105 Considering the aggressive misinformation campaigns run by "AstroTurf " groups and other organizations, the responses of physicians to affirmatively misleading and suggestive surveys are not surprising. Worse, immediately after the surveys are released, conservative media rush to announce that widespread defensive medicine is running our national health care system into the ground. 106 Civil justice opponents then point to these surveys in renewed efforts to compromise plaintiffs' rights across the nation, and the cycle starts anew. For example, in 2010, Representative Tom Price (R-GA) cited a single Gallup poll to suggest that 21 percent of all physician activity is defensive and costs the nation $650 billion. 107 Since physician surveys became commonplace, their results have varied wildly. For example, depending on the survey, from 21 to 98 percent of respondents claim to practice defensive medicine. 108 Yet these surveys all suffer from the same infirmities, including an availability bias, a strong response bias, a professional bias, unacceptably low response rates, lack of follow up questions, prompting, the failure to distinguish between purely defensive practices and medically appropriate practices, and a failure on the part of researchers to examine medical files of responding physicians.
Availability Bias
Like all of us, doctors are susceptible to psychological limitations that lead us to misperceive the frequency of events based on how recently we have seen examples of them. Ordinarily, people's assessment of the frequency of events is governed by "the ease with which instances or occurrences can be brought to mind." 109 This "availability" heuristic tends to break down, though, when people try to estimate the probability of events that are highly emotional, like being sued or dying of a shark attack. The problem with physician surveys is that, when asked about litigation or defensive medicine, the scariest anecdotes of seemingly unfair lawsuits that physicians, or their colleagues, have experienced may come to mind. With those emotional experiences or anecdotes fresh in their minds, survey respondents tend to overestimate the frequency of malpractice litigation and of their own "defensive" practices. 110 As discussed above, the best empirical research shows that doctors are not sued very often. Most victims of malpractice do not sue, and the majority of those who do file a claim have suffered an injury for which they are eligible for compensation. Indeed, the Harvard Medical Practice Study, discussed above, suggested that as few as 1.5 percent of medical injuries lead to a lawsuit.
111 This is a far cry from a litigation crisis. What these surveys are really doing is testing physicians' perceptions, and the availability bias explains why those perceptions are unlikely to be reliable indicators of anything other than physicians' exaggerated fears. 
Physician Surveys are Poorly Designed and Scientifically Unreliable
An example of the failings of physician surveys, a 2008 survey by the Massachusetts Medical Society, "found" that 83 percent of doctors in the state practice "defensive medicine," 18 to 28 percent of all testing is defensive, and the practice of "defensive medicine" costs the state over $1.4 billion a year.
112 While this study was neither peer-reviewed nor published, it garnered substantial attention and was presented, uncritically, in testimony by Dr. Stuart L. Weinstein to the House Committee on the Judiciary in January 2011.
113 Although the authors quietly acknowledged the numerous limitations of their work, including a low response rate, recall bias, validity and reliability issues in self-reporting, and social or professional pressures to over-report, 114 their preferred message was that "83 percent of the physicians surveyed reported that they practice defensive medicine."
115 This study, and others like it, suffers from four common defects that make such surveys especially unreliable.
Low Response Rates. Most physician surveys have unacceptably low response rates, ranging from 5 to 20 percent. Such low response rates can lead to what is known as "nonresponse bias" -when the only responses are from physicians who are inclined to respond due to bias or political motivations. The respondents are more likely to be those who agree with the myths about "defensive medicine" and wish to influence the debate. If survey responses were compulsory instead of voluntary, response rate and bias problems could be alleviated. In 2003, the AMA performed a national survey asking doctors whether they had made any practice changes and whether malpractice pressure motivated any of those changes. 116 Well over 90 percent of respondents said that litigation pressures were responsible for referrals, while 81.6 percent said malpractice concerns were responsible for ending certain services. However, when the GAO reviewed this survey in its 2003 report on malpractice and access to health care, it remarked that the survey had a surprisingly low response rate of just 10 percent and "did not identify responses associated with any particular service."
117 Tellingly, the GAO reported that the AMA refused to release its data because, while touting the results, it felt the response rates were "unacceptably low."
118 Nevertheless, the survey is routinely cited as evidence of the widespread practice of "defensive medicine."
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Response Bias. A similar problem is response bias, which, as the OTA pointed out in 1994, results from "the attention paid to defensive medicine by physician organizations, the news media, and policy makers" and leads to "physicians . . . exaggerat[ing] the impact of liability concerns on their practices in the hopes of eliciting a favorable political response." 120 Self-reporting by physicians is likely biased toward politically or socially acceptable responses, especially in light of the prompting that is typical of these surveys. 121 Driven by the misinformation campaigns of their medical associations, the insurance lobby, and conservative think tanks, physicians come to accept as true the premise that "defensive medicine" is a problem and therefore respond in predictable ways to surveys. No surveys mention this potential for bias or adjust their conclusions in kind.
Bad Questions, Lack of Follow Up. Many surveys use imprecise questions and then fail to ask relevant follow-up questions such as "If you indicated that you practice defensive medicine, how frequently, and with which patients?" Instead, surveys will simply ask whether the doctor has ever ordered unnecessary tests or procedures based on a threat of litigation. In spite of their training as scientists, survey designers never ask how frequently those tests or procedures were ordered, or whether they were ordered for certain ailments or for certain patients. Nor do surveys ever ask if other justifications contributed to, or even were the primary reason behind, a physician's decision. Because surveys are often designed with a political purpose, follow-up questions that aim to distinguish between differences in reasonable medical judgment and litigation-inspired "defensive medicine" would be inconvenient.
For example, in 2002, the American Academy of Orthopedic Surgeons released a report entitled "Medical Malpractice Insurance Concerns," which garnered a tiny 15 percent response rate. 122 Among those who responded, 48 percent said that the costs of malpractice insurance had caused them to change their practice, and 64 percent said that the change was to order more diagnostic tests. The survey did not ask what types of diagnostic tests are ordered; whether they were unnecessary or had actual benefits for the patients; whether, if completely unnecessary, patients were still billed for those additional tests; or even how frequently the additional diagnostic tests were ordered.
Prompting. Finally, most surveys expressly focus on "defensive medicine," using the phrase throughout the survey. Because of their past success, civil justice opponents have cemented the negative connotations of the phrase "defensive medicine" in the national psyche. Surveys that use the phrase place the topic of malpractice in the respondents' minds, triggering a recall of their negative views about litigation. In other words, the questions are specifically designed to exploit availability bias. As the OTA clinical scenario study discussed above showed, when doctors are not informed that "defensive medicine" is the subject of a survey, they will report a much lower frequency of the practice. 123 One recent survey took prompting to extraordinary heights. The AMA's Archives of Internal Medicine published a survey that asked whether physicians agreed with the following two statements: "Doctors order more tests and procedures than patients need to protect themselves against malpractice suits" and "Unnecessary use of diagnostic tests will not decrease without protections for physicians against unwarranted malpractice suits." 124 The results were not unexpected: 91 percent of physicians believe that doctors practice "defensive medicine" and 90.7 percent of physicians believe that "defensive medicine" will not decrease without protections for physicians from unwarranted malpractice suits.
The Texas Experience: Tort Reform Fails to Improve Worst Health Care System in U.S.
Civil justice opponents routinely laud Texas as a model for the supposed success of restricting medical malpractice plaintiffs' access to the courts. In 2003, Texas voters responded to a multimillion-dollar advertising campaign and passed Proposition 12, amending the Texas constitution to allow the legislature to cap non-economic damages in medical malpractice suits. Prior to passage, Proposition 12 supporters contended that high medical malpractice rates and "frivolous" lawsuits were responsible for the -very real and very problematic -doctor shortage in rural Texas. 131 Four years later, more doctors had begun to practice in Texas, but, contrary to the claim that this was a vindication for supporters of Proposition 12, those increases were being seen exclusively in wealthy counties. 132 Of the 152 counties that did not have an obstetrician in 2003, not one had gained the services of an obstetrician by September 2007 and just 13 have today. 133 In fact, according to Texas Medical Board data, before the caps were implemented, the number of doctors in Texas grew faster -at twice the rate of population growth -than after Proposition 12 passed, when that growth began to level off to match population growth. 134 The surprising conclusion is that the increased number of doctors practicing in Texas would have occurred in the absence of Proposition 12, and possibly at a higher rate. 135 Meanwhile, after Texas gave lobbyists the tort reform they worked so hard to win, the state's health care system is still in shambles. Total health care costs in the state -as measured by Medicare reimbursements -have risen at a rate twice the national average. 136 Texas also has the highest percentage, 26.8 percent, of uninsured citizens in the nation, including more than 1.3 million children. 
Conclusion
The United States spends more per capita on health care than any other nation -twice the average of the ten richest countries -and yet we suffer from an epidemic of medical errors that leads to the unnecessary deaths of too many of our citizens every year. Roughly 17 percent of our citizens lack health insurance, 125 our infant mortality is only slightly better than Serbia's, 126 and our life expectancy ranks 50th in the world. 127 We most certainly are not getting our money's worth. And while the civil justice system may be frustrating, it is the victims who suffer. Claims are processed at an exceedingly slow pace, administrative costs can be prohibitive, and the system sometimes fails to compensate the victims of medical malpractice as often, or as fully, as they deserve. Tort reform will do nothing to fix these flaws. But rather than focus on legitimate issues, the medical and insurance lobbies have chosen to pick a fight over the less than 3 percent of health care spending that may be attributable to medical malpractice litigation.
This report shows there is no persuasive evidence that litigation against physicians encourages them to practice defensively and make medical decisions solely, or even significantly, to avoid potential litigation. The best that opponents of the civil justice system can do to support their cause is cite unscientific surveys and severely limited economic research. The hard truth is that the benefits of tort reform accrue almost exclusively to corporate interests.
The real crisis in health care is the unacceptable number of medical errors killing and injuring hundreds of thousands every year. The latest research from the Department of Health and Human Services found that 15,000 Medicare patients die every month from adverse events and that 44 percent of those deaths are preventable, i.e. medical errors. 128 This equates to 79,200 preventable deaths each year in the Medicare system alone, far exceeding the shocking findings from the Institute of Medicine report a decade ago. 129 Recently the RAND Institute for Civil Justice published its findings linking adverse events with malpractice litigation. RAND researchers found that when the rate of adverse events decreased, so did malpractice litigation. 130 Not surprisingly, the reverse held true as well: when the rate of adverse events increased, so too did malpractice litigation. The civil justice system is not the cause of any alleged malpractice crisis; it merely sends a message to the health care system that it is not carefully enough monitoring for and preventing medical errors. Sadly, opponents of the civil justice system continue to focus on litigation and patients injured by medical malpractice as the problem. Yet the medical malpractice "reforms" they offer will not save a single patient from death or injury due to medical negligence. They should stop blaming the messenger and return to the business of putting their own houses in order. 21 One likely scenario is that a patient who suffers an adverse event alleges that a certain course of action was not taken, and therefore the physician was negligent. Later, in a deposition, the plaintiff may find out that the course of action was, in fact, taken, but not recorded. Alleging that such cases are frivolous simply because they are dropped ignores the design of the civil litigation system. Indeed, one study from 1991, explored the frivolous litigation claim in depth and found that cases with strong evidence on one side or the other are quickly dropped, while those cases with unclear evidence about negligence go further. Henry S. Farber & Michelle J. White, Medical Malpractice: An Examination of the Litigaiton Process, 22 RAND J. Econ. 199 (1991) . This supports the common sense notion that potential litigants only know that they were injured, not whether the doctor or hospital was negligent. The civil justice system's design is such that the initial stages of litigation help ferret out more information that leads to claims being resolved before going to trial. 
